Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice
Emilio J. Laserna‐Mendieta(University College Cork), Alfredo J. Lucendo, Cecílio Santander, Danila Guagnozzi, Antonia Perelló, Jésus Barrio, M. Ruiz-Ponce(Hospital General de Tomelloso), Sergio Casabona, Teresa Ramón y Cajal Asensio(Complejo Hospitalario Universitario de Albacete), Isabel Pérez‐Martínez(Hospital Universitario Central de Asturias), Edoardo Savarino(University of Padua), Ángel Arias(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), S. Riva, Antonio Guardiola(Hospital Universitario de Fuenlabrada), Juan A. Rodríguez-Oballe(Hospital Universitari Arnau de Vilanova)
Cited by 107
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Eosinophilic Esophagitis in Adults Is Associated With IgG4 and Not Mediated by IgE
|Gastroenterology|2014|487
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis
|New England Journal of Medicine|2022|452
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies
|Alimentary Pharmacology & Therapeutics|2019|309